Related Experiment Video
Updated: Jul 12, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
[What explains the increased rate of thromboses among the elderly? Pathophysiological data]
I Mahé1, C Caulin, J E Bergmann
1Service de Médecine A, Hôpital Lariboisière, Paris. isabelle.mahe@lrb.ap-hop-paris.fr
Presse Medicale (Paris, France : 1983)
|August 16, 2005
Summary
Aging is an independent risk factor for thrombosis, increasing the incidence of arterial and venous blood clots. Age-related changes in blood vessels and components promote a procoagulant state, contributing to clot formation.
Area of Science:
- Gerontology
- Vascular Biology
- Hematology
Context:
- The incidence of arterial and venous thrombosis significantly rises with advanced age.
- Elderly individuals often present with multiple comorbidities and risk factors for thrombotic events.
- Aging itself is increasingly recognized as a critical, independent risk factor for thrombosis.
Purpose:
- To elucidate the multifactorial nature of age-related thrombosis.
- To highlight the role of aging as an independent risk factor for thrombotic conditions.
- To explore the mechanisms underlying age-associated procoagulant states.
Summary:
- Age-related modifications in vascular structures and blood components contribute to a procoagulant state.
- Both arterial and venous thromboses are influenced by age, involving complex interactions of coagulation and platelet activation.
- The aging process intrinsically promotes conditions conducive to clot formation.
Impact:
- Provides a deeper understanding of the pathophysiology of thrombosis in the elderly.
- Informs the development of targeted preventative strategies for age-related thrombotic diseases.
- Highlights the need for age-specific considerations in managing thrombotic risk.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...